Dr. Essam Hamza reports

TREATMENT.COM AI GRANTS STOCK OPTIONS AND RSUS

Treatment.com AI Inc. has granted an additional 633,589 restricted share units (RSUs) and 330,132 stock options to continuing employees and consultants of Rocket Doctor Inc., the company's wholly owned subsidiary (see news release dated April 10, 2025).

The options are each exercisable for one common share of the company at an exercise price of 50 cents per share for a period of three years from the grant date and vest over a one-year term. The RSUs are valid for a term of three years and vest over a period of one year from the grant date. All options and RSUs are subject to the terms of the company's equity plans and applicable securities law hold periods.

About Treatment.com AI Inc.

Treatment.com AI is a company utilizing AI (artificial intelligence) and best clinical practices to positively improve the health care sector and impact current inefficiencies and challenges. With the input of hundreds of health care professionals globally, Treatment.com AI has built a comprehensive, personalized health care AI engine -- the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all health care professionals, as well as providing recommended tests (physical and lab), imaging and billing codes. The GLM helps health care professionals (doctors, nurses or pharmacists) reduce their administrative burden, creates more time for needed face-to-face patient appointments, and enables greater consistency in quality of patient support. Treatment.com AI's GLM platform, through supporting health care professionals, allows for the inclusion of disenfranchised communities.